These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3991785)

  • 1. [Dissolution processes and surface changes. 3. Determination of the surface with the BET process].
    Fürst W; Neubert R; Abendroth G; Lehmann U; Frenzel H; Weber U
    Pharmazie; 1985 Jan; 40(1):44-8. PubMed ID: 3991785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dissolution processes and surface alteration. 4. Determination of the "effective" surface].
    Neubert R; Fürst W; Frenzel H; Weber U
    Pharmazie; 1985 May; 40(5):336-8. PubMed ID: 4034639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simultaneous determination of disintegration and dissolution times of solid drug forms in a rotating flask dissolution tester. "Apparent" and "intrinsic" disintegration time].
    Koch HP; Faltis I; Mladenow H
    Pharmazie; 1987 Feb; 42(2):90-4. PubMed ID: 3602066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
    Koch HP; Pfeifer G
    Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technological methods for improving the solubility and increasing the dissolution rate of slightly soluble drugs (author's transl)].
    Krowczynski L
    Pharmazie; 1982 Jan; 37(1):79-83. PubMed ID: 7071117
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of aromatic hydrotropic drugs in pharmaceutical preparations by the surfactant-binding degree method.
    Pedraza A; Sicilia MD; Rubio S; Pérez-Bendito D
    Analyst; 2005 Jul; 130(7):1102-7. PubMed ID: 15965536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses].
    Kaniwa N; Katori N; Aoyagi N; Kojima S; Ishigame N; Seta Y; Shinba T; Fujiwara K; Nakai T; Oda Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):189-91. PubMed ID: 10097538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminar flux apparatus for dissolution studies of solid pharmaceutical formulations: a proposal.
    Rodriguez L; Zecchi V; Tartarini A; Orienti I; Ceschel GC
    J Pharm Belg; 1984; 39(6):355-60. PubMed ID: 6530637
    [No Abstract]   [Full Text] [Related]  

  • 9. [The release of effective substances from semi-solid drugs. Apparatus for determination of the release].
    Brunner B; Speiser P
    Arzneimittelforschung; 1970 Oct; 20(10):1610. PubMed ID: 5536435
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study.
    Panchagnula R; Kumar Bajpai A; Agrawal S; Ashokraj Y
    Pharmazie; 2006 Oct; 61(10):851-4. PubMed ID: 17069424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
    Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
    Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of interfacial energy from measures of the rats of dissolution].
    Jeannin C; Pakdee P; Carstensen JT
    Ann Pharm Fr; 1975; 33(8-9):433-40. PubMed ID: 1225123
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface composition and contact angle relationships for differently prepared solid dispersions.
    Dahlberg C; Millqvist-Fureby A; Schuleit M
    Eur J Pharm Biopharm; 2008 Oct; 70(2):478-85. PubMed ID: 18577450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
    Oliveira DC; Weigch A; Rolim CM
    Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of operative conditions during use of the revolving paddle dissolution apparatus].
    Benzina C; Jeannin C; Romier G; Verain A
    Pharm Acta Helv; 1983; 58(4):120-8. PubMed ID: 6867045
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.